StockData
CVS HEALTH Corp logo

CVS HEALTH Corp

CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$88.51−1.74 (-1.93%)

Close on Nov 2, 2026Market cap $113.20BP/E 23.5Yield 3.01%

Cvs Health IBNR Claims Liability by Quarter

IBNR (Incurred But Not Reported) Claims Liability ($M)

Cvs Health IBNR Claims Liability: $10,600M in Q2 2026, up 1.9% from a year earlier.

Latest, Q2 2026
10,600
Period ended Jun 30, 2026
Change on a year earlier
+1.9%
10,400 in Q2 2025
History
23 quarters
Since Q1 2019
Sources
1
CVS SEC 10-Q (XBRL us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet)

Where the Q2 2026 figure comes from

Source: CVS SEC 10-Q (XBRL us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet) ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedIBNR (Incurred But Not Reported) Claims Liability ($M)Year on yearSource
Q2 2026Jun 30, 202610,600+1.9%CVS SEC 10-Q (XBRL us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet) ↗
Q1 2026Mar 31, 202610,600-0.9%CVS SEC 10-Q (XBRL us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet) ↗
Q3 2025Sep 30, 202510,600-3.6%CVS SEC 10-Q (XBRL us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet) ↗
Q2 2025Jun 30, 202510,400-1.9%CVS SEC 10-Q (XBRL us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet) ↗
Q1 2025Mar 31, 202510,700-2.7%CVS SEC 10-Q (XBRL us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet) ↗
Q3 2024Sep 30, 202411,000+23.6%CVS SEC 10-Q (XBRL us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet) ↗
Q2 2024Jun 30, 202410,600+21.8%CVS SEC 10-Q (XBRL us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet) ↗
Q1 2024Mar 31, 202411,000+37.5%CVS SEC 10-Q (XBRL us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet) ↗
Q3 2023Sep 30, 20238,900+12.7%CVS SEC 10-Q (XBRL us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet) ↗
Q2 2023Jun 30, 20238,700+8.7%CVS SEC 10-Q (XBRL us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet) ↗
Q1 2023Mar 31, 20238,000+1.3%CVS SEC 10-Q (XBRL us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet) ↗
Q3 2022Sep 30, 20227,900+16.2%CVS SEC 10-Q (XBRL us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet) ↗
Q2 2022Jun 30, 20228,000+25.0%CVS SEC 10-Q (XBRL us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet) ↗
Q1 2022Mar 31, 20227,900+21.5%CVS SEC 10-Q (XBRL us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet) ↗
Q3 2021Sep 30, 20216,800+17.2%CVS SEC 10-Q (XBRL us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet) ↗
Q2 2021Jun 30, 20216,400+18.5%CVS SEC 10-Q (XBRL us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet) ↗

Cite this data

StockData. (2026). Cvs Health IBNR Claims Liability ($M), quarterly Q1 2019–Q2 2026 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/med-payable-ibnr

See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.